U.S. markets closed

Genocea Biosciences, Inc. (GNCA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3000-0.0400 (-1.71%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
1,359
1,359
0
0
0
Operating Expense
47,395
48,348
38,989
39,518
52,637
Operating Income
-46,036
-46,989
-38,989
-39,518
-52,637
Net Non Operating Interest Income Expense
-1,400
-1,380
-946
-1,021
-1,455
Other Income Expense
4,592
4,655
985
12,728
-2,618
Pretax Income
-42,844
-43,714
-38,950
-27,811
-56,710
Net Income Common Stockholders
-42,844
-43,714
-38,950
-27,811
-56,710
Average Dilution Earnings
-
-8,067
-
-
-
Diluted NI Available to Com Stockholders
-50,911
-51,781
-38,950
-27,811
-56,710
Basic EPS
-
-0.98
-1.89
-2.72
-15.84
Diluted EPS
-
-1.11
-1.89
-2.72
-15.84
Basic Average Shares
-
44,436
20,644
10,320
3,575
Diluted Average Shares
-
46,553
20,644
10,320
3,575
Total Operating Income as Reported
-46,036
-46,989
-38,989
-39,518
-55,255
Total Expenses
47,395
48,348
38,989
39,518
52,637
Net Income from Continuing & Discontinued Operation
-42,844
-43,714
-38,950
-27,811
-56,710
Normalized Income
-51,806
-52,603
-39,936
-42,568
-54,092
Interest Income
-
-
-
-
250
Interest Expense
1,400
1,380
946
1,021
1,705
Net Interest Income
-1,400
-1,380
-946
-1,021
-1,455
EBIT
-41,444
-42,334
-38,004
-26,790
-55,005
EBITDA
-40,201
-
-
-
-
Reconciled Depreciation
1,243
1,138
1,097
1,088
1,516
Net Income from Continuing Operation Net Minority Interest
-42,844
-43,714
-38,950
-27,811
-56,710
Total Unusual Items Excluding Goodwill
8,962
8,889
986
14,757
-2,618
Total Unusual Items
8,962
8,889
986
14,757
-2,618
Normalized EBITDA
-49,163
-50,085
-37,893
-40,459
-50,871
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0